PRF Technologies (PRFX) Equity Average (2021 - 2025)
PRF Technologies (PRFX) recorded quarterly Equity Average of $8.5 million in Q4 2025, up 65.44% on a QoQ basis from $5.1 million in Q2 2025, and up 7927.65% year-over-year from $105796.8 in Q4 2024.
PRF Technologies (PRFX) Equity Average (2021 - 2025) Analysis & Trends
PRF Technologies has disclosed Equity Average across 5 years of filings, most recently posting $8.5 million for Q4 2025.
- Quarterly Equity Average rose 7927.65% year-over-year to $8.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.5 million (up 7927.65% YoY) and the FY2025 annual result came in at $5.2 million, up 14.39% from the prior year.
- Equity Average improved to $8.5 million in Q4 2025, from $5.1 million in the prior quarter.
- Over five years, Equity Average peaked at $19.2 million in Q3 2021 and troughed at -$108500.0 in Q4 2024.
- A 5-year average of $10.0 million and a median of $8.5 million in 2025 frame the typical range for Equity Average.
- Annual changes were most pronounced in 2024 — Equity Average tumbled 101.37% — and 2025, when it soared 7927.65%.
- Tracing PRFX's Equity Average over 5 years: stood at $18.8 million in 2021, then sank by 34.94% to $12.2 million in 2022, then tumbled by 35.02% to $7.9 million in 2023, then plunged by 101.37% to -$108500.0 in 2024, then surged by 7927.65% to $8.5 million in 2025.
- Business Quant data shows PRFX's Equity Average at $8.5 million in Q4 2025, $5.1 million in Q2 2025, and -$108500.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | 8.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.49 Mn |
| Jun 30, 2025 | 5.13 Mn |
| Dec 31, 2024 | -108,500.00 |
| Jun 30, 2024 | -96,500.00 |
| Mar 31, 2024 | 4.54 Mn |
| Dec 31, 2023 | 7.94 Mn |
| Sep 30, 2023 | 7.81 Mn |
| Jun 30, 2023 | 7.93 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 12.22 Mn |
| Sep 30, 2022 | 14.31 Mn |
| Jun 30, 2022 | 15.95 Mn |
| Mar 31, 2022 | 17.39 Mn |
| Dec 31, 2021 | 18.78 Mn |
| Sep 30, 2021 | 19.24 Mn |